EPINEPHrine
Lack of Assurance of Sterility
Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.
14,535 recalls, newest first.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Crystallization; identified as Buprenorphine free base
Defective Container: Customer complaints for leaking bottles and dispensing issues.
Superpotent Drug
Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.
Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.
Failed Impurities/Degradation Specifications
cGMP Deviations: Product manufactured with contaminated raw ingredient.
cGMP Deviations: Product manufactured with contaminated raw ingredient.
Crystallization: Product appears to be turbid.
Labelling: Incorrect Exp. Date
CGMP Deviations: Other lots recalled because they were manufactured using common ingredients as the contaminated lot
CGMP Deviations: Other lots recalled because they were manufactured using common ingredients as the contaminated lot
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.